Patient Advocate Foundation →
Case management, co-pay relief fund, and legal counseling for patients with chronic, life-threatening, or debilitating illness including cancer.
Financial aid
Cancer treatment is expensive even with insurance. The organizations below are the most established, most trusted resources for co-pay relief, drug costs, transportation, lodging, and legal questions. All are free to apply. Some have limited funding windows — apply early.
Every major oncology drug has a manufacturer patient-assistance program. Click through to the drug's page to see Medicare cost data, the full program details, eligibility, and phone number.
| Drug | Class | Manufacturer program | Details |
|---|---|---|---|
| Keytruda pembrolizumab | Immunotherapy (PD-1 inhibitor) | Merck Access Program for KEYTRUDA | Cost + programs → |
| Opdivo nivolumab | Immunotherapy (PD-1 inhibitor) | BMS Access Support | Cost + programs → |
| Yervoy ipilimumab | Immunotherapy (CTLA-4 inhibitor) | BMS Access Support | Cost + programs → |
| Tecentriq atezolizumab | Immunotherapy (PD-L1 inhibitor) | Genentech Access Solutions | Cost + programs → |
| Herceptin trastuzumab | Targeted antibody (HER2) | Genentech Access Solutions | Cost + programs → |
| Perjeta pertuzumab | Targeted antibody (HER2) | Genentech Access Solutions | Cost + programs → |
| Kadcyla ado-trastuzumab emtansine | Antibody-drug conjugate (HER2) | Genentech Access Solutions | Cost + programs → |
| Enhertu fam-trastuzumab deruxtecan-nxki | Antibody-drug conjugate (HER2) | AstraZeneca Access 360 | Cost + programs → |
| Avastin bevacizumab | Targeted antibody (VEGF) | Genentech Access Solutions | Cost + programs → |
| Xgeva denosumab | Bone-targeted (RANKL inhibitor) | See drug page | Cost + programs → |
| Ibrance palbociclib | Targeted oral (CDK4/6 inhibitor) | Pfizer Oncology Together | Cost + programs → |
| Verzenio abemaciclib | Targeted oral (CDK4/6 inhibitor) | See drug page | Cost + programs → |
| Xtandi enzalutamide | Hormonal therapy (AR inhibitor) | Pfizer Oncology Together | Cost + programs → |
| Tagrisso osimertinib | Targeted oral (EGFR inhibitor) | AstraZeneca Access 360 | Cost + programs → |
| Lynparza olaparib | Targeted oral (PARP inhibitor) | AstraZeneca Access 360 | Cost + programs → |
Disease-specific foundations fund copay assistance for particular cancers. Funds open and close — check the linked page for current availability.
Data last checked 2026-04-21. Program eligibility and fund availability change — always verify at the program's website before applying.
Case management, co-pay relief fund, and legal counseling for patients with chronic, life-threatening, or debilitating illness including cancer.
Professional oncology social workers, limited financial assistance for co-pays, transportation, home care, and child care.
Co-pay, premium, and deductible relief for insured patients; fund availability varies by disease.
Premium and co-pay assistance; specific disease funds open and close.
Searchable directory aggregating dozens of cancer-specific financial assistance programs in one place.
Searchable database of patient assistance programs from pharmaceutical manufacturers — often the fastest way to get expensive cancer drugs at reduced or zero cost.
Comprehensive database of pharmaceutical manufacturer patient-assistance programs.
Co-pay relief for specific blood cancers when funds are open; enrollment is time-limited each year.
Patient navigation and financial assistance for breast cancer patients.
Pancreatic cancer research funding + patient services including clinical trial navigation.
Volunteer drivers for transportation to cancer treatment appointments.
Free flights on corporate jets for cancer patients traveling to treatment.
Free air transportation for patients traveling to medical care.
Affordable lodging near hospitals for out-of-town patients and families during treatment.
Free legal and financial navigation education — insurance appeals, SSDI, FMLA, employment rights.
Key tactic: ask your cancer center's social worker or financial counselor on day one — most centers have staff dedicated to navigating these programs. Also check the pharmaceutical manufacturer's website for every drug you're prescribed; most have patient- assistance programs not listed in aggregate directories.
We do not receive any compensation for listing these resources. They are here because they help cancer patients.